If workplace drug testing were effective, shouldn't we be seeing a DECREASE in positivity rates?
There is a better way... SOBEREYE measures impairment risk from any cause, on-the-job when it matters most!
Read Quest Diagnostic Press Release - Aug. 25, 2020
“There is no question that before COVID-19, rates of workplace drug positivity were trending in the wrong direction, based on our Quest Diagnostics data, The enormous strain caused by COVID-19 may prove to be an accelerant on this disturbing trend,” said Dr. Barry Sample, senior director of science and technology, Quest Diagnostics. “Organizations will need to consider the impact of COVID-19 not only on workplace safety but also as a health concern for their employees for some time to come.”